Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison

Chetan Sharma,Madhusudan Ganigara,Caroline Galeotti,Joseph Burns,Fernando M. Berganza,Denise A. Hayes,Davinder Singh-Grewal,Suman Bharath,Sujata Sajjan,Jagadeesh Bayry

DOI: https://doi.org/10.1038/s41584-021-00709-9

IF: 32.286

2021-10-29

Nature Reviews Rheumatology

Abstract:Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the more severe coronavirus disease 2019 (COVID-19) described in adults. However, SARS-CoV-2 is also associated with a widely reported but poorly understood paediatric systemic vasculitis. This multisystem inflammatory syndrome in children (MIS-C) has features that overlap with myocarditis, toxic-shock syndrome and Kawasaki disease. Current evidence indicates that MIS-C is the result of an exaggerated innate and adaptive immune response, characterized by a cytokine storm, and that it is triggered by prior SARS-CoV-2 exposure. Epidemiological, clinical and immunological differences classify MIS-C as being distinct from Kawasaki disease. Differences include the age range, and the geographical and ethnic distribution of patients. MIS-C is associated with prominent gastrointestinal and cardiovascular system involvement, admission to intensive care unit, neutrophilia, lymphopenia, high levels of IFNγ and low counts of naive CD4+ T cells, with a high proportion of activated memory T cells. Further investigation of MIS-C will continue to enhance our understanding of similar conditions associated with a cytokine storm.

rheumatology